
People with severe mental illness more likely to die early from cardiovascular disease, report finds
pharmafile.com | November 18, 2026 | News story | |Â Â BHF, Cardiology, Pharmacy, Psychiatry, cardiology, mental health, statinsÂ
People living with severe mental illness in England are around four times more likely to die prematurely from cardiovascular disease than the general population, according to a report from the British Heart Foundation (BHF) and three partner organisations.
The report, Left Behind: A Policy Response to Cardiovascular Inequalities in Severe Mental Illness, identifies inequalities in prevention, diagnosis and treatment, with people affected less likely to receive timely cardiovascular care.
Evidence cited in the report indicates that people with severe mental illness are 47% less likely to undergo cardiac interventions and 15% less likely to have a recent statin prescription. Up to 66% of patients with severe mental illness may also have undetected cardiovascular disease before dying from a cardiovascular cause.
The report identifies deprivation, stigma and fragmented health services as contributing factors. Patient accounts describe physical symptoms being dismissed as part of mental illness, while separate mental and physical health services can leave people struggling to navigate care.
The BHF, Centre for Mental Health, Equally Well UK and the Royal College of Psychiatrists are calling for action including improved smoking cessation and weight management support, stronger follow-up through NHS annual health checks, and better integration between psychiatric and cardiology services.
John Maingay, director of policy and influencing at the BHF, said people with severe mental illness faced barriers to effective cardiovascular care despite their increased risk, and called for more equitable access to prevention, diagnosis and treatment.
Related Content

PlaqueTec coronary disease trial reaches 100 patients across eight NHS centres
PlaqueTec’s BIOPATTERN clinical trial has recruited its 100th patient and expanded to eight NHS specialist …

Medtronic secures CE Mark for new cardiac pacing portfolio
Medtronic has received CE Mark approval for its Vitalis portfolio of five pacemakers, including a …

East London pharmacies pilot cholesterol-lowering injections to cut waiting times
A pilot scheme in east London is offering cholesterol-lowering injections at community pharmacies to help …





